2022
DOI: 10.1111/j.1755-3768.2022.178
|View full text |Cite
|
Sign up to set email alerts
|

Decreased glucose metabolism and glutamine synthesis in the retina of a transgenic mouse model of Alzheimer’s disease

Abstract: PurposeVisual changes are some of the earliest symptoms that patients with Alzheimer’s disease (AD) experience1. Pathophysiological processes such as amyloid‐β plaque formation, vascular changes, neuroinflammation, and loss of retinal ganglion cells (RGCs) have been detected in the retina of AD patients and animal models1. However, little is known about the molecular processes that underlie retinal neurodegeneration in AD. The cellular architecture and constant sensory activity of the retina impose high metabo… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles